Deciphera Pharmaceuticals (DCPH) Tops Q2 EPS by 6c
Get Alerts DCPH Hot Sheet
Join SI Premium – FREE
Deciphera Pharmaceuticals (NASDAQ: DCPH) reported Q2 EPS of ($0.60), $0.06 better than the analyst estimate of ($0.66). Revenue for the quarter came in at $32.5 million versus the consensus estimate of $30.58 million.
For earnings history and earnings-related data on Deciphera Pharmaceuticals (DCPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mobileye (MBLY) misses estimates for Q1 earnings, revenue; shares slip
- Southwest Airlines (LUV) stock tumbles after missing Q1 earnings, revenue expectations
- Merck (MRK) hikes outlook for 2024 as Q1 print beats analyst estimates
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!